Biosimilars

All articles by Biosimilars

Five things for pharma marketers to know: Wednesday, November 22, 2017
Five things for pharma marketers to know: Wednesday, November 22, 2017
November 22, 2017
3:49 pm

WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium’s Xtampza over Purdue’s OxyContin

Five things for pharma marketers to know: Wednesday, November 15, 2017
Five things for pharma marketers to know: Wednesday, November 15, 2017
Kevin McCaffrey
November 15, 2017
3:13 pm

FDA approves AstraZeneca asthma drug; Senate tax reform bill would repeal Obamacare mandate; J&J drops Remicade biosimilar lawsuit

Why haven’t biosimilars gained ground in the U.S.?
Why haven’t biosimilars gained ground in the U.S.?
Kevin McCaffrey
October 25, 2017
7:37 pm

Two years after the first biosimilar approval in the U.S., biosimilars have yet to match sales forecasts. What is their path forward?

Five things for pharma marketers to know: Wednesday, October 25, 2017
Five things for pharma marketers to know: Wednesday, October 25, 2017
Virginia Lau
October 25, 2017
2:30 pm

FDA develops resources about biosimilars for HCPs; Biogen negotiates royalties for experimental Alzheimer’s drug; GSK Q3 sales driven by HIV, respiratory drugs

Five things for pharma marketers to know: Monday, October 23, 2017
Five things for pharma marketers to know: Monday, October 23, 2017
Kevin McCaffrey
October 23, 2017
2:25 pm

Biosimilars could save $54 billion in next decade; White House requests drug-pricing task force; FDA approves GSK shingle vaccine

Five things for pharma marketers to know: Wednesday, September 20, 2017
Five things for pharma marketers to know: Wednesday, September 20, 2017
Kevin McCaffrey
September 20, 2017
2:26 pm

Pfizer sues J&J over Remicade contracts; drugmakers trim sales forces for rare-disease drugs; Roche’s oncology business under siege from biosimilars

Five things for pharma marketers to know: Tuesday, September 19, 2017
Five things for pharma marketers to know: Tuesday, September 19, 2017
Jaimy Lee
September 19, 2017
1:30 pm

Only three of the seven FDA-approved biosimilars are available for sale; Teva to sell off women’s health portfolio; the FDA approves GSK’s COPD combo

Five things for pharma marketers to know: Friday, September 15, 2017
Five things for pharma marketers to know: Friday, September 15, 2017
Jaimy Lee
September 15, 2017
2:00 pm

The FDA approves first cancer biosimilar; it also approves Bayer’s new lymphoma drug; clinical-trial participation for gynecological cancer drops

Five things for pharma marketers to know: Monday, August 28, 2017
Five things for pharma marketers to know: Monday, August 28, 2017
Kevin McCaffrey
August 28, 2017
2:36 pm

Gilead to acquire Kite; the FDA issues fewest number of warning letters since 2008; the regulator approves BI’s Humira biosimilar

Five things for pharma marketers to know: Friday, August 25, 2017
Five things for pharma marketers to know: Friday, August 25, 2017
Kevin McCaffrey
August 25, 2017
2:23 pm

Google surveys for depression; patients with diabetes that adhere to their regimen had fewer ER visits; Biogen, Samsung scores Humira biosimilar approval in EU

  • From Our Partners